Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer…
Pharmaceuticals, Biotechnology and Life Sciences
Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer…
Net Revenue up 23%, with Strong Subscription-Based Revenue GrowthLAS VEGAS, Nov. 14, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB:…
– Expanded executive team as Lourie Zak appointed Chief Financial Officer – – Extended clinical focus on systemic administration in small cell…
Acquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca.Record revenue of $6.27M, representing an increase of…
– SNK01 Phase I autologous clinical program demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer’s Disease, expect…
WATERTOWN, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…
– Continuing to Evaluate Strategic Options for the Company and the Pipeline of Genetic Medicines, including HMI-103 – BEDFORD, Mass., Nov.…
SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on…
Company to host conference call on Wednesday, November 15, 2023 at 8:00 a.m. ETBOSTON and ATLANTA, Nov. 14, 2023 (GLOBE…
Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the…